Literature DB >> 18772239

Different outcomes of unliganded and liganded estrogen receptor-alpha on neurite outgrowth in PC12 cells.

Yohann Mérot1, François Ferrière, Luc Gailhouste, Guillaume Huet, Frédéric Percevault, Christian Saligaut, Gilles Flouriot.   

Abstract

A precise description of the mechanisms by which estrogen receptor-alpha (ERalpha) exerts its influences on cellular growth and differentiation is still pending. Here, we report that the differentiation of PC12 cells is profoundly affected by ERalpha. Importantly, depending upon its binding to 17beta-estradiol (17betaE2), ERalpha is found to exert different effects on pathways involved in nerve growth factor (NGF) signaling. Indeed, upon its stable expression in PC12 cells, unliganded ERalpha is able to partially inhibit the neurite outgrowth induced by NGF. This process involves a repression of MAPK and phosphatidylinositol 3-kinase/Akt signaling pathways, which leads to a negative regulation of markers of neuronal differentiation such as VGF and NFLc. This repressive action of unliganded ERalpha is mediated by its D domain and does not involve its transactivation and DNA-binding domains, thereby suggesting that direct transcriptional activity of ERalpha is not required. In contrast with this repressive action occurring in the absence of 17betaE2, the expression of ERalpha in PC12 cells allows 17betaE2 to potentiate the NGF-induced neurite outgrowth. Importantly, 17betaE2 has no impact on NGF-induced activity of MAPK and Akt signaling pathways. The mechanisms engaged by liganded ERalpha are thus unlikely to rely on an antagonism of the inhibition mediated by the unliganded ERalpha. Furthermore, 17betaE2 enhances NGF-induced response of VGF and NFLc neuronal markers in PC12 clones expressing ERalpha. This stimulatory effect of 17betaE2 requires the transactivation functions of ERalpha and its D domain, suggesting that an estrogen-responsive element-independent transcriptional mechanism is potentially relevant for the neuritogenic properties of 17betaE2 in ERalpha-expressing PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772239     DOI: 10.1210/en.2008-0449

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Bisphenol S Triggers the Migration and Invasion of Pheochromocytoma PC12 Cells via Estrogen-Related Receptor α.

Authors:  Yuefeng Jia; Ruixia Sun; Xuemei Ding; Caixia Cao; Xuecheng Yang
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

2.  Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.

Authors:  Sumiko Yoshida; Ken-Ichi Aihara; Yasumasa Ikeda; Yuka Sumitomo-Ueda; Ryoko Uemoto; Kazue Ishikawa; Takayuki Ise; Shusuke Yagi; Takashi Iwase; Yasuhiro Mouri; Matomo Sakari; Takahiro Matsumoto; Ken-Ichi Takeyama; Masashi Akaike; Mitsuru Matsumoto; Masataka Sata; Kenneth Walsh; Shigeaki Kato; Toshio Matsumoto
Journal:  Circulation       Date:  2013-05-30       Impact factor: 29.690

3.  Unliganded estrogen receptor alpha promotes PC12 survival during serum starvation.

Authors:  François Ferriere; Denis Habauzit; Farzad Pakdel; Christian Saligaut; Gilles Flouriot
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

4.  Neuroprotective effects of ginsenosides Rh1 and Rg2 on neuronal cells.

Authors:  Xiao-Fan Li; Cathy Nga-Ping Lui; Zhi-Hong Jiang; Yung Kin-Lam Ken
Journal:  Chin Med       Date:  2011-05-19       Impact factor: 5.455

5.  The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion.

Authors:  Yu-Long Ma; Pei Qin; Yan Li; Lan Shen; Shi-Quan Wang; Hai-Long Dong; Wu-Gang Hou; Li-Ze Xiong
Journal:  BMC Neurosci       Date:  2013-10-09       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.